All terms
Market SegmentsStrategic Landscape
Women's Health Devices
Devices addressing reproductive health, pelvic floor, and OB/GYN care.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
Women's health spans contraception (IUDs, implants), endometrial ablation, fibroid treatment, pelvic floor and incontinence devices, breast biopsy and imaging (Hologic), and fetal/maternal monitoring. The segment covers fertility, contraception, pregnancy monitoring, menopause, breast health and pelvic floor devices. Some products, such as transvaginal mesh, have faced heavy FDA safety actions. Investment has grown, but clinical evidence and payment can be hard to secure. What the regulation says
Regulatory bodies such as the FDA evaluate Women's Health Devices under various classifications depending on their intended use and technology, often involving specific guidance documents related to reproductive health, mammography, or maternal-fetal medicine. The EU MDR (Medical Device Regulation) also classifies these devices based on risk, leading to varying requirements for clinical evidence and conformity assessment. For instance, devices with an aesthetic or non-medical intended purpose fall under MDR, but generally Class IIa or higher; contraceptives are typically Class IIb.What this means in practice
Historically underfunded; FemTech investment surged post-2020. Reimbursement and patient pay-mix vary dramatically by sub-segment.Examples
- A company developing an AI-powered mammography device must adhere to FDA guidance on Medical Devices Containing Artificial Intelligence or Machine Learning-Based Software, in addition to specific mammography regulations.
- A manufacturer of an intravaginal ring for contraception must conduct biocompatibility testing per ISO 10993 and demonstrate efficacy and safety through rigorous clinical trials, as per the device classification, e.g., Class IIb under EU MDR.
- A startup creating a wearable sensor for fetal monitoring needs to consider data privacy regulations like HIPAA in the US or GDPR in the EU, alongside performance standards for medical electrical equipment like IEC 60601-1.
Common pitfalls
- •A common pitfall is failing to account for sex-specific physiological differences in device design and clinical trial enrollment, potentially leading to suboptimal efficacy or safety for women.
- •Another mistake is overlooking the unique cybersecurity and privacy considerations for sensitive health data related to reproductive health or personal wellness devices.
- •Companies sometimes misinterpret reimbursement codes, leading to commercialization delays or market access issues.
- •Inaccurate labeling or promotional claims that overstate benefits specific to women's health can lead to regulatory scrutiny and enforcement actions.
Frequently asked questions
Device classification for Women's Health Devices depends on their intended use, risk profile, and mechanism of action, as defined by regulations like FDA 21 CFR Part 860 or EU MDR Annex VIII. This classification dictates the regulatory pathway, including premarket submission requirements and postmarket surveillance obligations.
Related terms
Grouped by themeMore in Market Segments
· Same categoryMarket Segments
Aesthetic & Energy-Based Devices
Lasers, RF, ultrasound, cryolipolysis, and IPL systems used for medical and cosmetic indications, body contouring, hair removal, skin tightening, vascular lesions.
Market Segments
AI Imaging Software
Software that analyzes medical images to triage, detect, or quantify disease.
Market Segments
Cardiac Rhythm Management(CRM)
Implantable and external devices that monitor and treat cardiac arrhythmias, pacemakers, ICDs, CRT devices, and insertable cardiac monitors.
Market Segments
Cardiovascular Devices
Devices for diagnosing, monitoring, or treating cardiovascular disease.
Cited by
Where this term appears across MedTech Terms.
Ecosystems (1)
Sources
4 sourcesSources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
Tier 2Regulator guidance and consensus· 1Tier 4Trade press and expert commentary· 3
Link health: 4 verified· last checked 2026-06-20· added official documents checked 2026-11-01
ACOG·1AdvaMed·1MedTech Europe·1FDA·1
- 1ACOGTier 4 VerifiedACOGacog.org
- 2AdvaMed - Industry ReportsTier 4 VerifiedAdvaMedadvamed.org
- 3MedTech Europe - Facts & FiguresTier 4 VerifiedMedTech Europemedtecheurope.org
- 4Breast ImplantsTier 2 VerifiedFDAfda.gov
Inline markers like [1] jump to the matching reference above.